Search DubaiPRNetwork.com

Home >> Banking & Investments

Dubai Investments acquires stake in Globalpharma for 100% ownership

Thursday, February 7, 2019/ Editor -  

Share

Home >> Banking & Investments

Dubai, February 7, 2019: Dubai Investments PJSC [DFM: DIC], the diversified leading company listed on the Dubai Financial Market, today announced the acquisition of an additional 66% stake in Globalpharma. Following the acquisition, made through Dubai Investments Industries, the pharmaceuticals company will now be a wholly owned subsidiary of Dubai Investments.

In 2014, Dubai Investments divested a 66% stake and had continued to hold a minority 34% equity in the subsidiary.
  
Khalid Bin Kalban, Managing Director and CEO of Dubai Investments PJSC, said: “Our original investment in Globalpharma was well timed and good for the growth of the healthcare sector in the UAE and region. We see the strategic benefit for making this acquisition. It forms part of the Dubai Investments growth strategy, and underscores our commitment to creating more value for our shareholders. 

“Our healthcare portfolio includes different stakes in KCH Healthcare LLC, Clemenceau Medical Centre, tie ups with hospital operators such as NMC in Dubai Investments Park and Mirdif Hills. These investments not only achieve key business objectives for Dubai Investments and support the Dubai economy, they also contribute to the wellbeing of the UAE, improve the reputation of Dubai as a hub for world-class medical care and align with the long term plans of the UAE government for sustainability and progress in fields such as health and science.”

Established in 1998 and headquartered in Dubai Investments Park, Globalpharma grew to become a market leader in certain generic medicines with a strong regional footprint. Globalpharma manufactures and markets pharmaceutical products in more than 14 countries across the GCC, Middle East and neighbouring markets.

Globalpharma manufactures and commercializes pharmaceutical products under CGMP (current good manufacturing practice) conditions including antibiotics, cardiovascular, anti-ulcerants, analgesic, NSAIDs (Nonsteroidal anti-inflammatory drugs), food supplements, vitamins, anti-diabetics, respiratory products and anti-histamine formulations. 


Previous in Banking & Investments

Next in Banking & Investments


Home >> Banking & Investments Section

Latest Press Release

New Peugeot 508 The Radical Saloon Makes Its Middle East Debut

Canadian University Dubai gets prestigious International Advertising Association ...

UAE Team Emirates' Main Man Martin Aiming for Major Success in the Ardennes Clas ...

Representing a 5% increase YOYý Etisalat Group Reports consolidated Net Profit o ...

DHL Express announces strategic partnership with Vinculum Solutions to facilitat ...

Dubai Islamic Bank 1st Quarter 2019 Financial Results

Nissan launches bold and powerful refreshed 2019 Maxima in the Middle East

Spectacular Show Jumping Season to Come to an End with Emirates Longines Final i ...

The Region's First Single-use Plastic Free Flight by Etihad Airways Touches Down ...

Al Ghurair Centre Unveils the Initial Phase of the New Generation Reel Cinema Ex ...

Premier Motors and Maserati host ‘Le Donne Di Maserati' – a stylish evening

Swissotel Al Ghurair Welcomes the Holy Month With Irresistible Ramadan Offers

Sharjah Chamber of Commerce and Industry organizes first of its kind “Sharjah Da ...

LIN SCAN successfully inspects unpiggable loading line in UAE using state of the ...

Participate in the UAE's largest Music Monkeys class ‘Music for Smiles' to raise ...

Turkish Cargo continued its growth in a shrinking air cargo market.

MBRU Issues Doctors Tolerance Pledge in Presence of UAE Minister of Tolerance

Dubai Customs honors female winners of Al Thuraya Award in its 1st edition

Splash Island- Spring Summer'19 Fashion Runway

Union Coop Declares “26.5 % Growth in Net Profit for First Quarter 2019”